Federal Register of Legislation - Australian Government

Primary content

PB 8 of 2020 Determinations/Health as made
This instrument amends the National Health (Listed drugs on F1 or F2) Determination 2010 to add one drug to F1, move one currently listed drug from F1 to F2 and add one drug currently listed on the Combination Drug List to F2.
Administered by: Health
Registered 31 Jan 2020
Tabling HistoryDate
Tabled HR04-Feb-2020
Tabled Senate04-Feb-2020
To be repealed 18 Aug 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

PB 8 of 2020

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated 29 January 2020

 

 

 

 

 

 

 

 

 

THEA DANIEL

 

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 1).

         (2)   This Determination may also be cited as PB 8 of 2020.

2              Commencement

                This Determination commences on 1 February 2020.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Ciclesonide

 

Insert

Cinacalcet

 

[2]     Schedule 1, after item dealing with Tioguanine

 

Omit

Tiotropium

 

[3]     Schedule 2, after item dealing with Ezetimibe and rosuvastatin

 

Insert

Ezetimibe with atorvastatin

 

[4]     Schedule 2, after item dealing with Tinidazole

 

Insert

Tiotropium